Sildenafil: A new oral therapy for erectile dysfunction

Drugs of Today

Volumn 35, Issue 3, 1999, Pages 211-217

  Noss, Mark Bradley ^a   Christ, George J ^a   Melman, Arnold ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PAPAVERINE; PROSTAGLANDIN E1; PROSTAVASIN; QUAZINONE; ROLIPRAM; SILDENAFIL; ZAPRINAST;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFICACY; DRUG METABOLISM; DRUG SAFETY; DRUG STRUCTURE; DYSPEPSIA; ERECTILE DYSFUNCTION; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; REVIEW; RHINITIS; VISUAL DISORDER;

EID: 0032935216     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.1999.35.3.533850     Document Type: Review

References (33)

1. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993, 270: 83-90.
2. Feldman, H.A., Goldstein, I., Hatzichristou. D.G. et al. Impotence and its medical and psychological correlates: Results of the Massachusetts Male Aging Study. J Urol 1994, 151: 54-61.
3. Morales, A., Heaton, J.P.W., Johnston, B. et al. Oral and topical treatment of erectile dysfunction: Present and future. Urol Clin North Am 1995, 22(4): 879-86.
4. Cookson, M.S., Nadig, P.W. Long term results with vacuum constriction device. J Urol 1993, 149: 290-4.
5. Padma-Nathan, H., Hellstrom, W.J.G., Kaiser, F.E. et al. Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group. New Engl J Med 1997, 336: 1-7.
6. Linet, O.I., Ogrinc, F.G. et al. Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. The Alprostadil Study Group. New Engl J Med 1996, 334: 873-7.
7. Fallon, B. Intracavernous injection therapy for male erectile dysfunction. Urol Clin North Am 1995, 22(4): 833-45.
8. Lewis, R.W. Long term results of penile prosthetic implants. Urol Clin North Am 1995, 22(4): 847-56.
9. Sharaby, J.S., Benet, A.E., Melman, A. Penile revascularization. Urol Clin North Am 1995 22(4): 821-32.
10. Morales, A., Condra, M., Owen, J.A. et al. Is yohimbine effective in the treatment of organic impotence? Results of a controlled trial. J Uro 1987, 137: 1168-72.
11. Ernst, E., Pittler, M.H. Yohimbine for erectile dysfunction: A systematic review and meta-analysis of randomized clinical trials. J Uro 1998, 159: 433-6.
12. Saenz de Tejada, I., Ware, J.C., Blanco, R. et al. Pathophysiology of prolonged penile erection associated with trazodone use. J Uro 1991, 145: 60-4.
13. Meinhardt, W., Schmitz, P.I.M., Kropman, R.F. et al. Trazodone, a double blind trial for treatment of erectile dysfunction. Int J Impot Res 1997, 9: 163-5.
14. Montague, D.K., Barada, J.H., Belker, A.M. et al. Clinical guidelines panel on erectile dysfunction: Summary report on the treatment of organic erectile dysfunction. The American Urological Association. J Urol 1996, 156: 2007-11.
15. Lerner, S.E., Melman, A., Christ, G.J. A review of erectile dysfunction: New insights and more questions. J Urol 1993, 149: 1246-55.
16. Melman, A., Christ, G.J., Hirsch, M.S. Anatomy and physiology of the penis. In: Impotence: Diagnosis and Management of Erectile Dysfunction. Bennet, A.M. (Ed.). W.B. Saunders Co.: Toronto 1994, 19-30.
17. Carter, A.J., Ballard, S.A., Naylor, A.M. Effect of selective phosphodiesterase type 5 inhibitor sildenafil on erectile function in anesthetized dog. J Urol 1998, 160: 242-6.
18. Burnett, A.L. Nitric oxide in the penis: Physiology and pathology. J Urol 1997, 157: 320-4.
19. Chuang, AT., Strauss, J.D., Murphy, R.A. et al. Sildenafil, a type-5 cGMP phosphodiesterase inhibitor, specifically amplifies endogenous cCMP-dependent relaxation in rabbit corpus cavernosum smooth muscle in vitro. J Urol 1998, 160: 257-61.
20. Beavo, J.A. Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms. Physiol Rev 1995, 75: 725-48.
21. Boolell, M., Geri-attee, S., Gingell, J.C. et al. Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol 1996, 78: 257-61.
22. Stief, C.G., Uckert, S., Becker, A.J., Truss, M.C., Jonas, U. The effect of the specific phosphodiesterase (PDE) inhibitors on human and rabbit cavernous tissue in vitro and in vivo. J Urol 1998, 159: 1390-3.
23. Moreland, R.B., Goldstein, I., Traish, A. Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells. Life Sei 1998, 62(20): PL 309-18.
24. Boolell, M., Allen, M.J., Ballard, S.A. et al. Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996, 8: 47-52.
25. TM) in the treatment of erectile dysfunction. Int J Impot Res 1998, 10: 69-74.
26. Jeremy, J.Y., Ballard, S.A., Naylor, A.M. et al. Effects of sildenafil, a type 5 cGMP phosphodiesterase inhibitor, and papaverine on cyclic GMP and cyclic AMP levels in the rabbit corpus cavernosum in vitro. Br J Urol 1997, 79: 958-63.
27. Ballard, S.A., Gingell, J.C., Tang, K. et al. Effects of sildenafil on relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 1998, 159: 2164-71.
28. Cooper, J.D.H., Muirhead, D.C., Taylor, J.E. et al. Development of an assay for the simultaneous determination of sildenafil (Viagra) and its metabolite (UK-103,320) using automated sequential trace enrichment of dialysates and high-performance liquid chromatography. J Chromatogr B 1997, 701: 87-95.
29. Packer, M., Carver, J.R., Rodeheffer, R.J. et al. Effect of milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. New Engl J Med 1991, 325: 1468-75.
30. Goldstein, I., Lue, T.F., Padma-Nathan, H. et al. Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. New Engl J Med 1998, 338(20): 1397-404.
31. Rendell, M.S., Rajfer, J., Wicker, P.A. et al. Sildenafil for treatment of erectile dysfunction in men with diabetes: A randomized controlled trial. Sildenafil Diabetes Study Group. JAMA 1999, 281: 421-6.
32. Rosen, R.C., Riley, A., Wagner, G. et al. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997, 49: 822-30.
33. Lolley, R.N., Lee, R.H. Phosphodiesterase dysfunction, cyclic GMP accumulation, and visual cell degeneration in early-onset inherited blindness. Adv Cycl Nucleotide Protein Phosphorylation Res 1984, 17: 315-27.